Drug Pipeline

JS212 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
1
Top Sponsors
Active Studies by Phase
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07484724 A Study Evaluating the Safety and Efficacy of JS212 Combination Therapy in Patients With… Advanced Esophageal Squamous Cell Carcinoma Recruiting
NCT07503756 JS212 Combination Therapies in Metastatic Colorectal Cancer Metastatic Colorectal Cancer Recruiting
NCT06868836 Phase II Clinical Study of JS207 (PD-1/VEGF Bispecific Antibody) Combination Therapies in… Non-squamous Non-small Cell Lung Cancer Recruiting
Sponsors Running JS212 Trials
Disease Areas
Get alerts when JS212 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free